{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:32:08Z","timestamp":1792798328373,"version":"4.5.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T00:00:00Z","timestamp":1714694400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.clml.2024.05.006","type":"journal-article","created":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T02:12:40Z","timestamp":1714788760000},"page":"e277-e282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of Previous Allogeneic Hematopoietic Stem Cell Transplantation on Chimeric Antigen Receptor (CAR) T Cell Treatment for Relapsed\/Refractory Multiple Myeloma"],"prefix":"10.1016","volume":"24","author":[{"given":"Janine","family":"Kirchberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luise","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8463-5179","authenticated-orcid":false,"given":"Patrick","family":"Born","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Morgner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"F\u00fcrst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Heyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0919-7730","authenticated-orcid":false,"given":"Enrica","family":"Bach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandy","family":"Brueckner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madlen","family":"Jentzsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5433-8750","authenticated-orcid":false,"given":"Song-Yau","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"B\u00f6ttcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8239-002X","authenticated-orcid":false,"given":"Georg-Nikolaus","family":"Franke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"Schrezenmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Platzbecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Merz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8398-285X","authenticated-orcid":false,"given":"Vladan","family":"Vu\u010dini\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.clml.2024.05.006_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm9072180","article-title":"Allogeneic transplantation in multiple myeloma\u2014does it still have a place?","volume":"9","author":"Gahrton","year":"2020","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.clml.2024.05.006_bib0002","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3390\/cancers14010055","article-title":"Allogeneic stem cell transplantation in multiple myeloma","volume":"14","author":"Greil","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.clml.2024.05.006_bib0003","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1007\/s00277-021-04514-y","article-title":"Long-term outcome after allogeneic stem cell transplantation in multiple myeloma","volume":"100","author":"Luoma","year":"2021","journal-title":"Ann Hematol"},{"issue":"1","key":"10.1016\/j.clml.2024.05.006_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/ejh.14051","article-title":"CAR T cell therapy in multiple myeloma, where are we now and where are we heading for?","volume":"112","author":"Fischer","year":"2024","journal-title":"Eur J Haematol"},{"issue":"8","key":"10.1016\/j.clml.2024.05.006_bib0005","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1056\/NEJMoa2024850","article-title":"Idecabtagene vicleucel in relapsed and refractory multiple myeloma","volume":"384","author":"Munshi","year":"2021","journal-title":"N Engl J Med"},{"issue":"10297","key":"10.1016\/j.clml.2024.05.006_bib0006","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0140-6736(21)00933-8","article-title":"Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b\/2 open-label study","volume":"398","author":"Berdeja","year":"2021","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.clml.2024.05.006_bib0007","doi-asserted-by":"crossref","first-page":"609.e1","DOI":"10.1016\/j.jtct.2023.06.010","article-title":"Idecabtagene vicleucel is well tolerated and effective in relapsed\/refractory myeloma patients with prior allogeneic stem cell transplantation","volume":"29","author":"John","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"3","key":"10.1016\/j.clml.2024.05.006_bib0008","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/bjh.19244","article-title":"Chimeric antigen receptor and bispecific T-cell engager therapies in multiple myeloma patients with prior allogeneic transplantation","volume":"204","author":"Hammons","year":"2024","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1016\/j.clml.2024.05.006_bib0009","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.clml.2023.08.012","article-title":"Ciltacabtagene autoleucel in patients with prior allogeneic stem cell transplant in the CARTITUDE-1 study","volume":"23","author":"Htut","year":"2023","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"35\u201336","key":"10.1016\/j.clml.2024.05.006_bib0010","article-title":"Beschluss der Bundes\u00e4rztekammer \u00fcber die erste Fortschreibung der Richtlinie zur Herstellung und Anwendung von h\u00e4matopoetischen Stammzellzubereitungen","volume":"120","year":"2019","journal-title":"Dtsch Arztebl Int"},{"issue":"1","key":"10.1016\/j.clml.2024.05.006_bib0011","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s12185-007-0018-7","article-title":"ISHAGE-based single-platform flowcytometric analysis for measurement of absolute viable T cells in fresh or cryopreserved products: CD34\/CD133 selected or CD3\/CD19 depleted stem cells, DLI and purified CD56+CD3\u2212 NK cells","volume":"87","author":"Koehl","year":"2008","journal-title":"Int J Hematol"},{"key":"10.1016\/j.clml.2024.05.006_bib0013","series-title":"R: A Language and Environment for Statistical Computing","year":"2020"},{"issue":"4","key":"10.1016\/j.clml.2024.05.006_bib0014","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.bbmt.2018.12.758","article-title":"ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells","volume":"25","author":"Lee","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"10.1016\/j.clml.2024.05.006_bib0015","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1111\/trf.17030","article-title":"Apheresis for chimeric antigen receptor T-cell production in adult lymphoma patients","volume":"62","author":"Harrer","year":"2022","journal-title":"Transfusion (Paris)"},{"issue":"2","key":"10.1016\/j.clml.2024.05.006_bib0016","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/bjh.18831","article-title":"Risk factors for CAR-T cell manufacturing failure among DLBCL patients: a nationwide survey in Japan","volume":"202","author":"Jo","year":"2023","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1016\/j.clml.2024.05.006_bib0017","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1200\/JCO.22.01365","article-title":"Idecabtagene vicleucel for relapsed\/refractory multiple myeloma: real-world experience from the myeloma CAR T consortium","volume":"41","author":"Hansen","year":"2023","journal-title":"J Clin Oncol"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265024001769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265024001769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T04:27:37Z","timestamp":1724473657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265024001769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":16,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2152265024001769"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2024.05.006","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Previous Allogeneic Hematopoietic Stem Cell Transplantation on Chimeric Antigen Receptor (CAR) T Cell Treatment for Relapsed\/Refractory Multiple Myeloma","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2024.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}